NUSADAILY.COM – JAKARTA – Renowned respiratory disease expert in China Prof. Zhong Nanshan estimates that 60-70 percent of the world’s population will be affected by COVID-19 with a death rate of close to seven percent.
“If there is no intervention, COVID-19 will likely affect 60-70 percent of the global population, with a death rate approaching seven percent,” he was quoted as saying by the Global Times, Saturday.
The health expert who was born in Nanjing, Jiangsu Province, also said patients infected with COVID-19 five days before and five days after the appearance of symptoms accompanied by severe illness had a high risk of death.
The pandemic will also continue into the next winter and spring, said the 83-year-old expert. Yang sparked a recommendation for a 14-day quarantine period after studying the transmission pattern of COVID-19 in Wuhan.
Zhong also advised the Chinese Government to carry out prevention and control with the people. Extends the range of nucleic acid tests, traces close contacts, and isolates patients.
Immunity can only be obtained through mass vaccination. Through global cooperation in one to two years, said the professor, who had pneumonia when SARS broke out in China in 2003.
Meanwhile, the Ministry of Science and Technology of China, Friday (18/9). 11 domestic-made COVID-19 vaccines have entered clinical trials, four of which have entered the third phase of clinical trials.
More than 100,000 Chinese citizens have been injected with the COVID-19 vaccine and after that they did not show any reaction.
Vaccine expert in Shanghai, Tao Lina, said that if 70 percent of Chinese citizens are successfully vaccinated. By 2021, at least 90 percent of Chinese citizens have been vaccinated so that preventive measures for COVID-19 will be more flexible and low cost.
China has also set up a national COVID-19 center as a first step towards international cooperation in dealing with the pandemic.
Head of the Chinese Center for Infectious Diseases Prevention and Control, Gao Fu. He said that the new institution would later collect virus samples and hold training on DNA sequencing related to COVID-19. (int1)